13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33383667 | New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models. | 2020 Dec 29 | 1 |
2 | 27813130 | P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors. | 2017 May | 1 |
3 | 25938863 | Identification of Possible Binding Sites for Morphine and Nicardipine on the Multidrug Transporter P-Glycoprotein Using Umbrella Sampling Techniques. | 2015 Jun 22 | 1 |
4 | 20354105 | Quantitative prediction of intestinal metabolism in humans from a simplified intestinal availability model and empirical scaling factor. | 2010 Jul | 1 |
5 | 14562035 | The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models. | 2003 Oct 20 | 1 |
6 | 11379779 | Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine. | 2001 May | 1 |
7 | 10772630 | In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. | 2000 May | 2 |
8 | 11145223 | Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. | 2000 Oct | 1 |
9 | 9657975 | Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. | 1998 Jul 15 | 3 |
10 | 7980629 | Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. | 1994 Oct 18 | 2 |
11 | 8094079 | Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. | 1993 Feb 5 | 1 |
12 | 1358068 | P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. | 1992 Oct 15 | 1 |
13 | 2569930 | Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. | 1989 Sep 15 | 1 |